Notice of Change to RFA-HL-14-001 "Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage II (CADET II) (UH2/UH3)"

Notice Number: NOT-HL-13-192

Key Dates
Release Date: August 22, 2013

Related Announcements
RFA-HL-14-001

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

On July 17, 2013, the NHLBI published Funding Opportunity Announcement (FOA) RFA-HL-14-001, "Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage II." The purpose of this Notice is to amend the FOA to allow foreign components within applications.  The following section of the FOA is revised accordingly:

Part 2. Full Text of Announcement

Section III.1 Eligible Applicants

Foreign Institutions

Current language:

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

New language:

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Michelle Freemer, M.D.
National Heart, Lung, and Blood Institute
Telephone:  301-435-0202
Email:  michelle.freemer@nih.gov

 


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices



NIH Office of Extramural Research Logo
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®



Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.